Al­ler­gan buys an ail­ing Re­pros, bag­ging a women’s health drug for the pipeline

Af­ter a lengthy deal spree, Al­ler­gan $AGN is go­ing shop­ping in the pen­ny stock aisle.

The com­pa­ny says it has struck a deal to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.